| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/03/2003 | CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | CA2459976A1 Opioid formulations having reduced potential for abuse |
| 04/03/2003 | CA2459943A1 Androstanes as androgen receptor modulators |
| 04/03/2003 | CA2459926A1 Screening and selection methods for statin drug combinations |
| 04/03/2003 | CA2459125A1 Substituted phenol compounds useful for anesthesia and sedation |
| 04/03/2003 | CA2458661A1 Methods of increasing endogenous testosterone levels |
| 04/03/2003 | CA2456281A1 Pyrane derivatives as both ace- and nep- inhibitors |
| 04/03/2003 | CA2453985A1 Receptors and membrane-associated proteins |
| 04/03/2003 | CA2446904A1 Delivery of drug esters through an inhalation route |
| 04/02/2003 | EP1298436A2 Beta-amyloid peptide (BAP) release inhibitor compounds for treating BAP-related diseases and methods for their identification |
| 04/02/2003 | EP1298223A2 Methods related to the A-C repeat Z-sequence upstream from the aldose reductase gene |
| 04/02/2003 | EP1297851A1 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 04/02/2003 | EP1297850A1 Medicinal preparations for treating sex hormone-dependent diseases |
| 04/02/2003 | EP1297841A1 Pancreatic langerhans beta cell proliferation promoter and apoptosis inhibitor, and screening of candidate compounds for the e drugs |
| 04/02/2003 | EP1297180A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 04/02/2003 | EP1297167A1 Tumour-cell specific gene expression and its use in cancer therapy |
| 04/02/2003 | EP1297152A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 04/02/2003 | EP1297147A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 04/02/2003 | EP1297138A2 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 04/02/2003 | EP1297130A2 G-protein coupled receptors |
| 04/02/2003 | EP1297127A2 Gpr22 modulators as appetite-control agents |
| 04/02/2003 | EP1297121A2 Purging of cells using viruses |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1297012A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 04/02/2003 | EP1297007A2 Mammalian protein phosphatases |
| 04/02/2003 | EP1297002A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 04/02/2003 | EP1297001A1 Amphipathic linear peptides and compositions containing same |
| 04/02/2003 | EP1296995A2 3'-prodrugs of 2'-deoxy-beta-l-nucleosides |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296948A2 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
| 04/02/2003 | EP1296947A1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT |
| 04/02/2003 | EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 04/02/2003 | EP1296931A2 Polyamine analogues as cytotoxic agents |
| 04/02/2003 | EP1296724A1 Bioadhesive composition and methods of preparation and use |
| 04/02/2003 | EP1296723A1 A medicinal aerosol formulation |
| 04/02/2003 | EP1296716A2 New formulation |
| 04/02/2003 | EP1296714A2 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 04/02/2003 | EP1296708A1 Use of secretin-receptor ligands in treatment of cystic fibrosis (cf) and chronic obstructive pulmonary disease (copd) |
| 04/02/2003 | EP1296693A1 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor. |
| 04/02/2003 | EP1296692A1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/02/2003 | EP1296690A2 METHOD FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS USING NUCLEOSIDE ANALOGUES |
| 04/02/2003 | EP1296687A2 Treatment of male sexual dysfunction |
| 04/02/2003 | EP1296683A2 Methods of treating neutrophil-related diseases with topical anesthetics |
| 04/02/2003 | EP1296679A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 04/02/2003 | EP1296678A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 04/02/2003 | EP1296675A2 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 04/02/2003 | EP1296672A1 Stable pharmaceutical product and formulation |
| 04/02/2003 | EP1296665A1 Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
| 04/02/2003 | EP1296661A2 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 04/02/2003 | EP1296656A2 Method for preparing a composition |
| 04/02/2003 | EP1296652A1 Topical pharmaceutical formulations and methods of treatment |
| 04/02/2003 | EP1296650A2 Methods and compositions for treating pain of the mucous membrane |
| 04/02/2003 | EP1296648A1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/02/2003 | EP1296633A1 Medicinal product package for eradication therapy |
| 04/02/2003 | EP1296590A2 A personal condition management system |
| 04/02/2003 | EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 04/02/2003 | EP1212312B1 Novel derivatives of flavones, xanthones and coumarins |
| 04/02/2003 | EP1129119B1 Silane copolymer coatings |
| 04/02/2003 | EP1124841B1 Substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them |
| 04/02/2003 | EP1121108B1 Novel therapeutic use of compounds with beta-3-agonist activity |
| 04/02/2003 | EP1083886B1 Drug delivery system comprising a tightly compacted solid medicament stock |
| 04/02/2003 | EP1043993B1 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 04/02/2003 | EP0993304B1 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative |
| 04/02/2003 | EP0986387B1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER |
| 04/02/2003 | EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 04/02/2003 | EP0946146B1 Use of aqueous medicament preparations for the production of propellent gas-free aerosols |
| 04/02/2003 | EP0914460B1 Vehicle for the transport of molecular substances |
| 04/02/2003 | EP0882029B1 Heterocyclic derivatives as antidiabetic and antiobesity agents |
| 04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
| 04/02/2003 | EP0702518B1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 04/02/2003 | CN1407990A C-aryl glucoside sgltz inhibitors |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1407903A Concomitant drugs for treating glaucoma |
| 04/02/2003 | CN1407902A Remedies for intractable wound |
| 04/02/2003 | CN1407901A Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy |
| 04/02/2003 | CN1407900A Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (MPIF-1) |
| 04/02/2003 | CN1407891A Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 04/02/2003 | CN1407890A Treatment of psoriasis |
| 04/02/2003 | CN1407887A Oral liquid compositions |
| 04/02/2003 | CN1407885A Histamine H2 antagonist effervescent composition |
| 04/02/2003 | CN1407857A 低聚糖混合物 Oligosaccharide mixture |
| 04/02/2003 | CN1104243C Use of aromatase inhibitors in prepn. of drug for treating relative androgend efficiency in men |
| 04/02/2003 | CN1104242C Use of epinastine in the treatment of pain |
| 04/02/2003 | CN1104238C Enteric-coated pharmaceutical compositions of mycophenolate |
| 04/01/2003 | US6541680 Mixture of choline, betaine, folic acid, vitamin B12, methionine and zinc |
| 04/01/2003 | US6541670 Antiinflammatory agents |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541649 Process for synthesis of novel cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules |
| 04/01/2003 | US6541523 Methods for treating or preventing fibromyalgia using very low doses of cyclobenzaprine |
| 04/01/2003 | US6541508 Water solubility; prodrug containing polyether oligomer |
| 04/01/2003 | US6541488 Compositions for treating arterial thrombosis and a factor Xa inhibitor |
| 04/01/2003 | US6541479 Calcium channel blockers |
| 04/01/2003 | US6541478 Smoking cessation treatments using naltrexone and related compounds |
| 04/01/2003 | US6541477 Inhibitors of p38-a kinase |
| 04/01/2003 | US6541463 Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use |
| 04/01/2003 | US6541462 Sphingomyelin enhancement of tumor therapy |
| 04/01/2003 | US6541220 Novel parathyroid hormone (PTH), parathyroid hormone related protein (PTHrP), receptors (PTH1R and PTH3R) isolated from zebrafish; vectors, host cells, recombinant methods for producing; use in identifying receptor agonists, antagonists |
| 04/01/2003 | US6541008 Vascular endothelial growth factor-like protein from orf viruses binds and activates mammalian VEGF receptor-2, and uses thereof |
| 04/01/2003 | US6540990 Topical application to the eye of an acetylcholine esterase inhibitor, such as a mercaptoethyltrimethylammonium salt, to improve visual acuity |
| 04/01/2003 | US6540983 A drug selected from an insulin analog, and/or amylin, a fluid propellant carrier, and a stabilizer comprising water added in addition to nascent formulation water; treating diabetes; inhalers |